Increased CD16 and CD57 levels and CD56+ lymphocyte numbers are reported in peripheral blood (PB) and BM samples of untreated patients with MM, respectively, compared with those of matched healthy volunteers. The gene discussed is NCAM1; the disease is Miyoshi myopathy.